Development of multivalent next-generation vaccine strategy against ancestral SARS-CoV-2 and emerging variants
A recent study demonstrated that intranasal (i.n.) delivery of COVID-19 vaccine in murine models elicits greater immune responses against the wildtype SARS-CoV-2 and its variants.